Ono Pharmaceutical
ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.
Launch date
Employees
Market cap
€6.3b
Enterprise valuation
€4.9b (Public information from Sep 2024)
Share price
JPY1969.5 4528.T
Osaka Osaka Prefecture (HQ)
Financials
Estimates*
JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 309.3b | 361.4b | 447.2b | 502.7b | 482.5b | 512.8b | 518.2b |
% growth | 6 % | 17 % | 24 % | 12 % | (4 %) | 6 % | 1 % |
EBITDA | 116.8b | 123.6b | 161.9b | 182.1b | 122.6b | 140.7b | 140.3b |
% EBITDA margin | 38 % | 34 % | 36 % | 36 % | 25 % | 27 % | 27 % |
Profit | 75.4b | 80.5b | 112.7b | 128.0b | 76.2b | 79.2b | 80.2b |
% profit margin | 24 % | 22 % | 25 % | 25 % | 16 % | 15 % | 15 % |
EV / revenue | 4.5x | 4.0x | 2.8x | 2.0x | 2.3x | 2.0x | 1.9x |
EV / EBITDA | 11.8x | 11.7x | 7.7x | 5.4x | 8.9x | 7.3x | 7.0x |
R&D budget | 62.4b | 75.9b | 95.3b | 112.2b | - | - | - |
R&D % of revenue | 20 % | 21 % | 21 % | 22 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Ono Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.